Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.3%

8 terminated out of 96 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

3%

3 trials in Phase 3/4

Results Transparency

16%

7 of 44 completed with results

Key Signals

7 with results85% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (22)
P 1 (12)
P 2 (12)
P 3 (2)
P 4 (1)

Trial Status

Completed44
Recruiting21
Unknown10
Terminated8
Not Yet Recruiting5
Withdrawn4

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 44 completed trials

Clinical Trials (96)

Showing 20 of 20 trials
NCT03508453Phase 2Withdrawn

IC14 for Treatment of Amyotrophic Lateral Sclerosis

NCT01900132Not ApplicableRecruiting

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

NCT02360891Completed

Study of Predictive Factors of Progression of Motor Neurone Disease

NCT07204977Phase 1Active Not Recruiting

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

NCT05183152Not ApplicableRecruiting

Non-invasive BCI-controlled Assistive Devices

NCT07543367Not ApplicableNot Yet Recruiting

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT07446114Not ApplicableRecruiting

Functional Outcomes and Control Using Synchron BCI - Canada

NCT07533903Not ApplicableNot Yet Recruiting

Functional Outcomes and Control Using Synchron BCI - Australia

NCT00004568RecruitingPrimary

Study of Inherited Neurological Disorders

NCT07491484Recruiting

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

NCT05354622Recruiting

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

NCT04944940Recruiting

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

NCT04380649Not ApplicableActive Not Recruiting

Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People

NCT05137665Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

NCT06450418Recruiting

Digital App for Speech & Health Monitoring

NCT05744310Not ApplicableRecruiting

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

NCT03487263Phase 1CompletedPrimary

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

NCT07127172Not ApplicableRecruiting

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

NCT07093268Phase 1Not Yet Recruiting

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

NCT03705390Phase 2Terminated

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

Scroll to load more

Research Network

Activity Timeline